

Results of Hypertonic Saline or Mannitol Clinical Trial for Treatment of Children with Severe TBI
Apr 25, 2022
Dr. Patrick Kochanek, a Distinguished Professor of Critical Care Medicine and director at the University of Pittsburgh, discusses groundbreaking findings from the ADAPT trial. He shares key insights on comparing hypertonic saline and mannitol in treating severe pediatric traumatic brain injury. Unexpected results regarding intracranial pressure measurement come to light, prompting a reevaluation of current treatment methodologies. Dr. Kochanek also highlights the challenges faced in pediatric trials and the potential impact on future clinical practices.
Chapters
Transcript
Episode notes
1 2 3 4 5
Intro
00:00 • 4min
Exploring Patient Characteristics in the ADAPT Trial
04:29 • 4min
Reevaluating Hyperosmolar Therapy in Pediatric TBI
08:06 • 9min
Comparative Efficacy of Hypertonic Saline and Mannitol in Pediatric TBI Management
16:42 • 4min
Clinical Trial Insights on TBI Treatments
20:49 • 8min